Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

265 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Efficacy of microwave ablation versus radiofrequency ablation for the treatment of hepatocellular carcinoma in patients with chronic liver disease: a randomised controlled phase 2 trial.
Vietti Violi N, Duran R, Guiu B, Cercueil JP, Aubé C, Digklia A, Pache I, Deltenre P, Knebel JF, Denys A. Vietti Violi N, et al. Among authors: aube c. Lancet Gastroenterol Hepatol. 2018 May;3(5):317-325. doi: 10.1016/S2468-1253(18)30029-3. Epub 2018 Mar 2. Lancet Gastroenterol Hepatol. 2018. PMID: 29503247 Clinical Trial.
[Radiofrequency thermal ablation of liver tumors].
Lermite E, Aubé C, Pessaux P, Arnaud JP. Lermite E, et al. Among authors: aube c. Presse Med. 2007 Jul-Aug;36(7-8):1127-34. doi: 10.1016/j.lpm.2006.12.008. Epub 2007 Jan 17. Presse Med. 2007. PMID: 17603921 Review. French.
Factors limiting complete tumor ablation by radiofrequency ablation.
Paulet E, Aubé C, Pessaux P, Lebigot J, Lhermitte E, Oberti F, Ponthieux A, Calès P, Ridereau-Zins C, Pereira PL. Paulet E, et al. Among authors: aube c. Cardiovasc Intervent Radiol. 2008 Jan-Feb;31(1):107-15. doi: 10.1007/s00270-007-9208-1. Epub 2007 Oct 30. Cardiovasc Intervent Radiol. 2008. PMID: 17968620
Steatosis degree, measured by morphometry, is linked to other liver lesions and metabolic syndrome components in patients with NAFLD.
Boursier J, Chaigneau J, Roullier V, Lainé F, Sandrini J, Michalak S, Hubert I, Dib N, Oberti F, Bertrais S, Hunault G, Deugnier Y, Rousselet MC, Cavaro-Ménard C, Gallois Y, Aubé C, Calès P; Study group UNAM-METABOL. Boursier J, et al. Among authors: aube c. Eur J Gastroenterol Hepatol. 2011 Nov;23(11):974-81. doi: 10.1097/MEG.0b013e32834a4d82. Eur J Gastroenterol Hepatol. 2011. PMID: 21904208
Efficacy and safety of selective internal radiotherapy with yttrium-90 resin microspheres compared with sorafenib in locally advanced and inoperable hepatocellular carcinoma (SARAH): an open-label randomised controlled phase 3 trial.
Vilgrain V, Pereira H, Assenat E, Guiu B, Ilonca AD, Pageaux GP, Sibert A, Bouattour M, Lebtahi R, Allaham W, Barraud H, Laurent V, Mathias E, Bronowicki JP, Tasu JP, Perdrisot R, Silvain C, Gerolami R, Mundler O, Seitz JF, Vidal V, Aubé C, Oberti F, Couturier O, Brenot-Rossi I, Raoul JL, Sarran A, Costentin C, Itti E, Luciani A, Adam R, Lewin M, Samuel D, Ronot M, Dinut A, Castera L, Chatellier G; SARAH Trial Group. Vilgrain V, et al. Among authors: aube c. Lancet Oncol. 2017 Dec;18(12):1624-1636. doi: 10.1016/S1470-2045(17)30683-6. Epub 2017 Oct 26. Lancet Oncol. 2017. PMID: 29107679 Clinical Trial.
265 results